This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

5 Stocks Under $10 With Big Upside Potential

Ariad Pharmaceuticals

Another under-$10 stock to consider is Ariad Pharmaceuticals (ARIA), a biopharmaceutical company focused on the discovery and development of drugs to provide therapeutic intervention in treating human diseases at the cellular level. This stock has been a market leader in 2011, with shares up over 80%.

If you take a look at the chart for Ariad Pharmaceuticals, you'll see that this stock has found big buying support at around $7.50 to $7.70 a share a number of times during the past six months. Every time the stock has hit those levels, it's bounced significantly higher and it has been a great buying opportunity.

Now the stock is approaching some levels that will trigger another big breakout if it can manage to trade above them. The first level to watch is the 50-day moving average at $9.58 a share. The second level is some major overhead resistance at around $10.70 a share. If both of those levels are taken out to the upside in the near future, then I think this stock can make another run at its July highs of $13.50 a share.

>>8 Biotech Stocks to Watch

Market-players should now watch for a breakout for a move above those levels on heavy volume. Look for volume that's tracking in close to or above its three-month average action of 3.86 million shares.

One could be a buyer of this stock on any notable weakness in anticipation of the breakout, or you could just wait for the breakout and then get long off strength. If you buy off weakness I would use a stop just below $9 a share. I would look to add to any long position once this stock takes out $10.70 with volume.

This is another heavily shorted stock with over 12% of the float sold short by the bears. This high short interest could fuel a sizable short-squeeze if we can get back above the 50-day and then above $10.70 in the coming days or weeks.

Ariad shows up on a list of Hot Biotech trades for Second-Half 2011.

5 of 6

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,031.14 +43.63 0.26%
S&P 500 1,984.13 -1.41 -0.07%
NASDAQ 4,518.9020 -48.6960 -1.07%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs